专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011031099A3 URSODEOXYCHOLIC ACID-SYNTHETIC HYDROTALCITE-EUDRAGIT HYBRID, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME 审中-公开
标题翻译： URSODEOXYCHOLIC ACID-SYNTHETIC HYDROTALCITE-EUDRAGIT HYBRID，含有它们的药物组合物及其制备方法
公开(公告)号：WO2011031099A3
公开(公告)日：2011-07-07
申请号：PCT/KR2010006192
申请日：2010-09-10
申请人： DAE WOONG PHARMA , CHOY JIN HO , CHOI GO EUN , PARK MYUNG CHUL , CHANG HEE CHUL
发明人： CHOY JIN HO , CHOI GO EUN , PARK MYUNG CHUL , CHANG HEE CHUL
IPC分类号： C07J9/00 , A61K31/575 , A61P1/16
CPC分类号： A61K31/575 , C07J9/005
摘要： The present invention relates to an ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition because of its bitter-taste-blocking effect and improved body absorption rate with high solubility.
摘要翻译：本发明涉及熊去氧胆酸 - 合成水滑石 - Eudragit杂交体，含有它们的药物组合物及其制备方法。根据本发明的熊去氧胆酸合成水滑石 - Eudragit杂交物作为药物组合物的活性成分是非常有用的，因为它具有苦味阻隔作用和改善的具有高溶解度的身体吸收速率。

2. 发明申请

WO2011031100A3 ARIPIPRAZOLE-BENTONITE-AEA HYBRID, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME 审中-公开
公开(公告)号：WO2011031100A3
公开(公告)日：2011-03-17
申请号：PCT/KR2010/006193
申请日：2010-09-10
申请人： DAEWOONG PHARMACEUTICAL CO., LTD. , CHOY, Jin Ho , OH, Yeon Ji , PARK, Myung Chul , CHANG, Hee Chul
发明人： CHOY, Jin Ho , OH, Yeon Ji , PARK, Myung Chul , CHANG, Hee Chul
IPC分类号： C07D403/12 , A61K31/4709 , A61P25/18
摘要： The present invention relates to an aripiprazole-bentonite-AEA hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The aripiprazole-bentonite-AEA hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition for treating psychiatric illness including schizophrenia and bipolar disorder because of its bitter-taste-blocking effect and improved body absorption rate with high solubility.

3. 发明申请

WO2011031100A2 ARIPIPRAZOLE-BENTONITE-AEA HYBRID, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME 审中-公开
标题翻译：亚油唑烷 - 膨润土混合物，含有它们的药物组合物及其制备方法
公开(公告)号：WO2011031100A2
公开(公告)日：2011-03-17
申请号：PCT/KR2010006193
申请日：2010-09-10
申请人： DAE WOONG PHARMA , CHOY JIN HO , OH YEON JI , PARK MYUNG CHUL , CHANG HEE CHUL
发明人： CHOY JIN HO , OH YEON JI , PARK MYUNG CHUL , CHANG HEE CHUL
IPC分类号： C07D403/12 , A61K31/4709 , A61P25/18
CPC分类号： A61K31/4709 , C07D215/22
摘要： The present invention relates to an aripiprazole-bentonite-AEA hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The aripiprazole-bentonite-AEA hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition for treating psychiatric illness including schizophrenia and bipolar disorder because of its bitter-taste-blocking effect and improved body absorption rate with high solubility.
摘要翻译：本发明涉及阿立哌唑 - 膨润土-AEA杂化物，含有它的药物组合物及其制备方法。根据本发明的阿立哌唑 - 膨润土-AEA杂化物作为用于治疗包括精神分裂症和双相性精神障碍在内的精神疾病的药物组合物的活性成分是非常有用的，因为其具有苦味阻滞效应和改善的具有高溶解度的身体吸收速率。

4. 发明申请

WO2011031099A2 URSODEOXYCHOLIC ACID-SYNTHETIC HYDROTALCITE-EUDRAGIT HYBRID, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME 审中-公开
标题翻译：尿嘧啶酸 - 合成水滑石 - 尿囊剂混合物，含有该组合物的药物组合物及其制备方法
公开(公告)号：WO2011031099A2
公开(公告)日：2011-03-17
申请号：PCT/KR2010006192
申请日：2010-09-10
申请人： DAE WOONG PHARMA , CHOY JIN HO , CHOI GO EUN , PARK MYUNG CHUL , CHANG HEE CHUL
发明人： CHOY JIN HO , CHOI GO EUN , PARK MYUNG CHUL , CHANG HEE CHUL
IPC分类号： C07J9/00 , A61K31/575 , A61P1/16
CPC分类号： A61K31/575 , C07J9/005
摘要： The present invention relates to an ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition because of its bitter-taste-blocking effect and improved body absorption rate with high solubility.
摘要翻译：本发明涉及熊脱氧胆酸合成水滑石-Eudragit混合物，含有它的药物组合物及其制备方法。根据本发明的熊去氧胆酸 - 合成水滑石-Eudragit混合物由于其苦味阻断效果和改善的身体吸收率和高溶解度而作为药物组合物的活性成分是非常有用的。

5. 发明申请

WO2006030993A1 INFORMATION CODE SYSTEM USING DNA SEQUENCES 审中-公开
标题翻译：使用DNA序列的信息代码系统
公开(公告)号：WO2006030993A1
公开(公告)日：2006-03-23
申请号：PCT/KR2004/002329
申请日：2004-09-14
申请人： CHOY, Jin-Ho , PARK, Man , OH, Jae-Min
发明人： CHOY, Jin-Ho , PARK, Man , OH, Jae-Min
IPC分类号： C12N15/00
CPC分类号： B82Y5/00 , C12Q1/68 , C12Q2563/185
摘要： The present invention provides a molecular level of DNA information code which uses a base pair sequence as an information code unit. Also, the present invention pr ovides a molecular code system which includes designing and coding DNA which is an information code unit; stabilizing the DNA information code by encapsulating it with an in organic capsule and coating the DNA-inorganic capsule to a medium; taking and extract ing the coated DNA information code which is present in a trace amount, collecting the DNA information code using a polypyrrole-maghemite nanohybrid; and amplifying the c ollected DNA information code using a polymerase chain reaction and reading the amplified DNA information code. According to the present invention, the DNA information c ode having high security is prepared by assigning a security unit to a DNA which has an excellent accumulating capacity, and then the DNA information code is stabilized so a s to be coated to a medium. Only the DNA information code may be extracted, collect ed, and read, if necessary. Thus, a unified molecular code system can be established.
摘要翻译：本发明提供了使用碱基对序列作为信息代码单元的DNA信息码的分子水平。另外，本发明涉及一种分子代码系统，其包括设计和编码作为信息代码单元的DNA; 通过将其封装在有机胶囊中并将DNA-无机胶囊包被在介质中来稳定DNA信息代码; 采集和提取以微量存在的包被的DNA信息代码，使用聚吡咯 - 磁赤铁矿纳米混合物收集DNA信息代码; 并使用聚合酶链反应扩增所选择的DNA信息代码并读取扩增的DNA信息码。根据本发明，通过将安全性单位分配给具有良好的累积能力的DNA，然后将DNA信息码稳定化以便涂覆在培养基上来制备具有高安全性的DNA信息。只有DNA信息代码可以提取，收集和阅读，如有必要。因此，可以建立统一的分子代码系统。

6. 发明申请

WO2005044722A1 METHOD FOR FORMING ZNO NANO-ARRAY AND ZNO NANOWALL FOR UV LASER ON SILICON SUBSTRATE 审中-公开
标题翻译：用于在硅基板上形成紫外线激光的ZNO纳米阵列和氮纳米管的方法
公开(公告)号：WO2005044722A1
公开(公告)日：2005-05-19
申请号：PCT/KR2004/002866
申请日：2004-11-06
申请人： NANOHYBRID CO., LTD. , CHOY, Jin-Ho , JANG, Eue-Soon , WON, Jung-Hee
发明人： CHOY, Jin-Ho , JANG, Eue-Soon , WON, Jung-Hee
IPC分类号： B82B3/00
CPC分类号： H01S5/347 , B82Y20/00 , B82Y30/00 , C30B7/10 , C30B29/16 , C30B29/62 , H01S5/021 , H01S5/341
摘要： Provided are low-temperature formation methods of a perfectly oriented ZnO nanorod array and a new-type ZnO nanowall array having a new crystal growth rate, morphology, and orientation, from ZnO nanoparticles coated on a substrate. The method of forming the ZnO nanorod array includes synthesizing ZnO nanoparticles, coating on a substrate the ZnO nanoparticles serving both as a buffer layer and a seed layer, and growing the ZnO nanoparticles into crystals in a nutrient solution containing Zn nitrate, Zn acetate, or a derivative thereof, and hexamethylenetetramine. The method of forming the ZnO nanowall array includes synthesizing ZnO nanoparticles,to coating on a substrate the ZnO nanoparticles serving both as a buffer layer and a seed layer, and growing the ZnO nanoparticles into crystals in a nutrient solution containing Zn acetate or its derivative and sodium citrate.
摘要翻译：提供了完全取向的ZnO纳米棒阵列的低温形成方法和具有新的晶体生长速率，形态和取向的新型ZnO纳米壁阵列，其由涂覆在基底上的ZnO纳米颗粒组成。形成ZnO纳米棒阵列的方法包括合成ZnO纳米颗粒，在衬底上涂覆用作缓冲层和种子层的ZnO纳米颗粒，并将ZnO纳米颗粒在含有硝酸锌，乙酸锌或其衍生物和六亚甲基四胺。形成ZnO纳米壁阵列的方法包括合成ZnO纳米颗粒，在衬底上涂覆用作缓冲层和种子层的ZnO纳米颗粒，并将ZnO纳米颗粒在含有乙酸锌或其衍生物的营养溶液中生长成晶体，以及柠檬酸钠。

7. 发明申请

WO2011031099A9 URSODEOXYCHOLIC ACID-SYNTHETIC HYDROTALCITE-EUDRAGIT HYBRID, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR PREPARING THE SAME 审中-公开
标题翻译：尿嘧啶酸 - 合成水滑石 - 尿囊剂混合物，含有该组合物的药物组合物及其制备方法
公开(公告)号：WO2011031099A9
公开(公告)日：2011-03-17
申请号：PCT/KR2010/006192
申请日：2010-09-10
申请人： DAEWOONG PHARMACEUTICAL CO., LTD. , CHOY, Jin Ho , CHOI, Go Eun , PARK, Myung Chul , CHANG, Hee Chul
发明人： CHOY, Jin Ho , CHOI, Go Eun , PARK, Myung Chul , CHANG, Hee Chul
IPC分类号： C07J9/00 , A61K31/575 , A61P1/16
摘要： The present invention relates to an ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition because of its bitter-taste-blocking effect and improved body absorption rate with high solubility.
摘要翻译：本发明涉及一种熊去氧胆酸合成水滑石-Eudragit混合物，一种含有该组合物的药物组合物及其制备方法。根据本发明的熊去氧胆酸合成水滑石的Eudragit混合动力车是作为因的药物组合物的有效成分非常有用的它的苦味阻断具有高溶解度的效果和改进的身体吸收率。

8. 发明申请

WO2006091009A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER COMPRISING LMH-RA COMPLEX 审中-公开
标题翻译：用于治疗包含LMH-RA复合物的癌症的药物组合物
公开(公告)号：WO2006091009A1
公开(公告)日：2006-08-31
申请号：PCT/KR2006/000600
申请日：2006-02-22
申请人： NANOHYBRID CO., LTD. , CHOY, Jin-ho , PARK, Taeun , KIM, Sang-tae , SON, You-hwan
发明人： CHOY, Jin-ho , PARK, Taeun , KIM, Sang-tae , SON, You-hwan
IPC分类号： A61K31/07 , A61P35/00
CPC分类号： A61K33/24 , A61K31/203 , A61K33/08 , A61K33/26 , A61K33/30 , A61K2300/00
摘要： Provided is a pharmaceutical composition for the treatment of liver cancer, including a layered metal hydroxide-retinoic acid (LMH-RA) hybrid as a novel drug delivery system which shows few side effects of retinoic acid, good drug stability, sustained drug release, and improved drug delivery efficiency.
摘要翻译：提供了用于治疗肝癌的药物组合物，包括层状金属氢氧化物视黄酸（LMH-RA）杂合物作为新型药物递送系统，其显示视黄酸的副作用很小，药物稳定性好，持续的药物释放和提高药物输送效率。

9. 发明申请

WO2005067979A1 AHYBRID OF ITRACONAZOLE WITH A LAYERED SILICATE 审中-公开
标题翻译：具有层状硅酸盐的异烟肼的混合物
公开(公告)号：WO2005067979A1
公开(公告)日：2005-07-28
申请号：PCT/KR2005/000181
申请日：2005-01-20
申请人： NANOHYBRID CO., LTD. , JUNG, Hyun , PARK, Taeun , CHOY, Jin-Ho
发明人： JUNG, Hyun , PARK, Taeun , CHOY, Jin-Ho
IPC分类号： A61K47/48
CPC分类号： A61K31/41 , A61K47/52
摘要： A hybrid of an itraconazole with a silicate obtained through an interface reaction between an aqueous dispersion of a Iayered silicate and a solution containing an itraconazole dissolved in a water-insoluble organic solvent, wherein the amount of the layered silicate in the hybrid is 0.01 % to 10% by weight, is provided.
摘要翻译：伊曲康唑与硅酸盐的水分散体与溶解在水不溶性有机溶剂中的伊曲康唑的溶液之间的界面反应得到的硅酸盐的混合物，其中混合物中层状硅酸盐的量为0.01％〜 10重量％。

10. 发明申请

WO2011052917A3 LAYERED DOUBLE HYDROXIDE VARIANT SEPIOLITE COMPOUND, AND METHOD FOR PREPARING SAME 审中-公开
标题翻译：层状双氢氧化异氰酸酯化合物及其制备方法
公开(公告)号：WO2011052917A3
公开(公告)日：2011-11-03
申请号：PCT/KR2010007057
申请日：2010-10-14
申请人： DANSUK IND CO LTD , UNIV EWHA IND COLLABORATION , CHOY JIN HO , PARK DAE HWAN , JANG MYUNG WOOK , LIM BYUNG GIL , MUN MIN HO
发明人： CHOY JIN HO , PARK DAE HWAN , JANG MYUNG WOOK , LIM BYUNG GIL , MUN MIN HO
IPC分类号： C01F7/00 , C01F5/00 , C22C21/06 , C22C23/02
CPC分类号： C01F7/005 , C01P2002/01 , C01P2002/22 , C01P2002/72 , C01P2002/77 , C01P2002/82 , C01P2002/86 , C01P2002/88 , C01P2004/03 , C01P2004/04
摘要： The present invention relates to a layered double hydroxide variant sepiolite compound and to a method for preparing same. In detail, the present invention relates to a layered double hydroxide variant sepiolite compound and to a method for preparing same wherein a thermal transformation process and a hydration process are performed on layered metal hydroxide which is an anionic compound, so that the layered double hydroxide variant sepiolite compound has a channel structure in which blocks and tunnels intersect each other in a crystallographic axis, and has physicochemical stability, a wide specific surface area, and porosity, and thus improved thermal properties. The sepiolite compound according to the present invention can be applied to a variety of fields including the production of thermal stabilizers, flame retardants, absorbents, filters, spandex, fillers, catalysts, decolorants, etc.
摘要翻译：本发明涉及层状双氢氧化物变体海泡石化合物及其制备方法。详细地说，本发明涉及层状双氢氧化物变体海泡石化合物及其制备方法，其中对作为阴离子化合物的层状金属氢氧化物进行热转化过程和水合过程，使得层状双氢氧化物变体海泡石化合物具有通道结构，其中块和隧道在结晶轴上相交，并且具有物理化学稳定性，较宽的比表面积和孔隙率，从而改善了热性能。根据本发明的海泡石化合物可以应用于各种领域，包括制备热稳定剂，阻燃剂，吸收剂，过滤剂，氨纶，填料，催化剂，脱色剂等。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式